Stay updated on MBG453 Combo in IPSS-R MDS Clinical Trial

Sign up to get notified when there's something new on the MBG453 Combo in IPSS-R MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MBG453 Combo in IPSS-R MDS Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated in the footer from v3.3.1 to v3.3.2. This is a minor site version update and does not affect the study information displayed.
    Difference
    0.0%
    Check dated 2025-12-01T18:00:04.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    In December 2023, Novartis terminated the sabatolimab clinical development program early after Phase II (MDS1) and Phase III (MDS2) failed to meet primary objectives. The termination was not due to safety concerns, and the 2025 revision added new sections such as Limitations and Caveats, Adverse Events, Outcome Measures, Baseline Characteristics, and Participant Flow.
    Difference
    0.6%
    Check dated 2025-11-24T15:01:19.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Removal of a government funding/status notice from the page; no trial record content or navigation is affected.
    Difference
    0.3%
    Check dated 2025-11-17T07:21:51.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The two screenshots display the same record history page with only cosmetic differences and no changes to the study data or status. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-03T01:23:59.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Page now includes an official operating-status notice and updates version to v3.2.0, replacing v3.1.0.
    Difference
    7%
    Check dated 2025-10-05T10:11:50.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.2%
    Check dated 2025-09-28T03:16:23.000Z thumbnail image

Stay in the know with updates to MBG453 Combo in IPSS-R MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MBG453 Combo in IPSS-R MDS Clinical Trial page.